Bibliography
- Reeves WG, Allen BR, Tattersall RB. Insulin-induced lipoatrophy an immune pathogenesis. Brit Med J 1980;1500-3
- Schernthaner G. Immunogenicity and allergenic potential of animal and human insulins. Diabetes Care 1993;16(Suppl 3):155-65
- Griffin ME, Feder A, Tamborlane WV. Lipoatrophy associated with lispro insulin in insulin pump therapy: an old complication, a new cause? Diabetes Care 2001;24:174
- Ampudia-Blasco FJ, Hasbum B, Carmena R. A new case of lipoatrophy with lispro insulin in insulin pump therapy: is there any insulin preparation free of complications? Diabetes Care 2003;26:953-4
- Arranz A, Andia V, López-Guzmán A. A case of lipoatrophy with Lispro insulin without insulin pump therapy. Diabetes Care 2004;27:625-6
- Al-Khenaizan S, Al Thubaiti M, Al Alwan I. Lispro insulin-induced lipoatrophy: a new case. Pediatr Diabetes 2007;8:393-6
- Hussein SF, Siddique H, Coates P, Green J. Lipoatrophy is a thing of the past, or is it? Diab Med 2007;24:1470-2
- Del Olmo MI, Campos V, Abellán P, A case of lipoatrophy with insulin detemir. Diabetes Res Clin Pract 2008;80:e20-21
- Ampudia-Blasco FJ, Girbes J, Carmena R. A case of lipoatrophy with insulin glargine. Diabetes Care 2005;28:2983
- Dziura M, Wasikowa R. Lipoatrophy after nuse of long acting insulin glargine analogue in a 32-year-old patient with type 1 diabetes. Pediatr Endocrinol Diabetes Metab 2008;14:61-3
- Szypowska A, Skórka A, Pańkowska E. Lipoatrophy associated with rapid-acting insulin analogues in young patients with type 1 diabetes mellitus. Pediatr Endocrinol Diabetes Metab 2008;14:117-18
- Radermecker RP, Pierard GE, Scheen AJ. Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs. Am J Clin Dermatol 2007;8:21-8
- Atlan-Gepner C, Bongrand P, Farnarier C, Insulin-induced lipoatrophy in type I diabetes. A possible tumor necrosis factor-alpha-mediated dedifferentiation of adipocytes. Diabetes Care 1996;19:1283-5
- Murao S, Hirata K, Ishida T, Takahara J. Lipoatrophy induced by recombinant human insulin injection. Intern Med 1998;37:1031-3
- Mu L, Goldmann JM. Human recombinant DNA insulin-induced lipoatrophy in a patient with type 2 diabetes mellitus. Endocr Pract 2000;6:151-2
- Beltrand J, Guilmin-Crepon S, Castanet M, Insulin allergy and extensive lipoatrophy in child with type 1 diabetes. Horm Res 2006;65:253-60
- Ramos AJ, Farias MA. Human insulin-induced lipoatrophy: a successful treatment with glucocorticoid. Diabetes Care 2006;29:926-7
- Lopez X, Castells M, Ricker A, Human insulin analog–induced lipoatrophy. Diabetes Care 2008;31:442-4
- Radermecker RP, Scheen AJ. Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues. Diabetes Metab Res Rev 2007;23:348-55
- Fineberg NS, Fineberg SG, Anderson JH, Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin. Diabetes 1996;45:1750-4
- Holmberg H, Mersebach H, Kanc K, Ludvigsson J; Insulin Aspart Study Group on Immunogenicity. Antibody response to insulin in children and adolescents with newly diagnosed Type 1 diabetes. Diabet Med 2008;25:792-7
- Lindholm A, Jensen LB, Home PD, Immune responses to insulin aspart and biphasic insulin aspart in people with type 1 and type 2 diabetes. Diabetes Care 2002;25:876-82
- Goykhman S, Drincic A, Desmangles JC, Rendell M. Insulin Glargine: a review 8 years after its introduction. Expert Opin Pharmacother 2009;10:705-18
- Kuerzel GU, Shukla U, Scholtz HE, Biotransformation of insulin glargine after subcutaneous injection in healthy subjects. Curr Med Res Opin 2003;19:34-40
- Chantelau E, Reuter M, Schotes S, Starke AA. Severe lipoatrophy with human insulin: successfully treated by CSII. Diabet Med 1993;10:580-1
- Roper NA, Bilous RW. Resolution of lipohypertrophy following change of short-acting insulin to insulin lispro (Humalog). Diabet Med 1998;15:1063-4
- Burgdorf WH, Plewig G, Wolff HH, Landthaler M, editors. Braun-Falco's dermatology. 3rd editon, Springer; 2009
- Herranz P, de Lucas R, Pérez-España L, Mayor M. Lipodystrophy syndromes. Dermatol Clin 2008;26:569-78
- Moreno S, Miralles C, Negredo E, Disorders of body fat distribution in HIV-1-infected patients. AIDS Rev 2009;11:126-34